Source of Support: None, Conflict of Interest: None
The efficacy and safety of betamethsone dipropionate 0.05% with salicylic acid 2% scalp lotion was evaluated in patients with moderate to server scalp psoriasis. Out of 150 patients with scalp psoriasis 75 Patients received PUVASOL alone and 75 patients received PUVASOL along with lotion 0.05% betamethsone dipropionate with 2% salicylic acid scalp application for3 weeks. The erythema, indurations, scales application for 3 weeks treatment course with combination therapy. At the end of therapy, 59(78.6%) of those patients receiving combination therapy had 75% improvement of their scalp psoriasis versus 26(34.6%) nose patients using PUVASOL alone. Complete clearing of the scalp was seen in 28 (37.3%) patients receiving therapy and 10 (13.3%) cases receiving treated with topical betamethasone dipropionate with salicylic acid appears to be safe and an effective treatment for scalp psoriasis.